FDA chief expects J&J pause to run 'a matter of days'

Federal officials expect their recommended pause on Johnson & Johnson COVID-19 vaccines will last "a matter of days," the head of the U.S. Food and Drug Administration said Tuesday.
Acting FDA Commissioner Dr. Janet Woodcock said the exact time frame will depend on what officials learn over the next few days in their review of six cases of a severe blood clot reported after receiving the J&J shot, which she said seems to be "extremely rare."
The FDA and the Centers for Disease Control and Prevention on Tuesday announced they were recommending a pause on delivering J&J vaccines while those reports of a combination of the blood clot and a low platelet count — from six women in the U.S. between the ages of 18 and 48, among a pool of more than 6.8 million J&J doses administered nationwide — are investigated. Subsequently, the Massachusetts Department of Health directed providers here to stop giving J&J vaccines while the review plays out.

Related Keywords

United States ,Massachusetts ,White House ,District Of Columbia ,Americans ,American ,David Rosman ,Jeff Zients ,Anne Schuchat ,Peter Marks ,Janet Woodcock ,Johnson ,Centers For Disease ,Drug Administration ,Biden Administration ,Pfizer ,Astrazeneca ,Massachusetts Department Of Health ,Massachusetts Medical Society ,Disease Control ,Massachusetts Department ,Biologics Evaluation ,Coordinator Jeff Zients ,J Amp ,Vaccine ,Fda ,ஒன்றுபட்டது மாநிலங்களில் ,மாசசூசெட்ஸ் ,வெள்ளை வீடு ,மாவட்டம் ஆஃப் கொலம்பியா ,அமெரிக்கர்கள் ,அமெரிக்கன் ,டேவிட் ரோஸ்மேன் ,பீட்டர் மதிப்பெண்கள் ,ஜேனட் மரக்கட்டை ,ஜான்சன் ,மையங்கள் க்கு நோய் ,ஃபைசர் ,மாசசூசெட்ஸ் துறை ஆஃப் ஆரோக்கியம் ,மாசசூசெட்ஸ் மருத்துவ சமூகம் ,நோய் கட்டுப்பாடு ,மாசசூசெட்ஸ் துறை ,உயிரியல் மதிப்பீடு ,ஜு ஆம்ப் ,டா ,